Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 6 results:
Συντάκτης Τίτλος [ Τύπος
] Έτος Φίλτρα: Συντάκτης is Maniadakis, Nikos [Clear All Filters]
(2017). Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.
Clinical Drug Investigation. 3720113350142914930161243078363366301713154614171321391617731648921111413285823092141331041430113112173333(98221823311234261451031644210713311062365432454625101839), 833 - 844.
(2018). Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece..
Clin Drug Investig. 38(5), 417-426.
(2018). Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
Clinical Drug Investigation. 3831184061314132015410373121437191919154637191436(511Suppl 2518942221193773988), 417 - 426.
(2012). Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study..
Eur J Epidemiol. 27(11), 857-66.
(2018). Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities..
J Glob Oncol. 4, 1-12.
(2009). XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis..
Curr Med Res Opin. 25(3), 797-805.
